Phase 1Not yet recruitingAge-related condition

A study to investigate safety and effectiveness of REM0045392 compared with placebo in healthy elderly participants and participants with Alzheimer’s disease (REMAD-06)

Sponsor

reMYND (Industry)

Enrolment

34 planned

Conditions

Alzheimer's disease

Ages

adults, older adults

Registry

CTIS2026-527490-11-00

Full record on the EU Clinical Trials Information System